This month, I was honoured to be a speaker for Junior Achievement of BC’s presentation on “The Future of Work and Emerging Careers” to showcase our thriving life sciences sector. Designed for children in grades four to 12, this event helps students explore their career goals - and what a joy it was to share the countless opportunities within the life sciences sector with the “next generation” of changemakers!
In keeping with the theme of new and upcoming opportunities, we’d like to share an open call for partners in talent and workforce development from The Digital Technology Supercluster. If you are an organization that is focused on digital skilling, workforce development and Equity, Diversity, and Inclusion, we encourage you to express your interest. Next Thursday, May 5th, Digital Technology Supercluster is also hosting a webinar entitled “IP strategies to enable scale-ups”, which is an opportunity to learn from industry thought leaders from the Innovation Asset Collective, Terramera and Northworks IP. We’re also thrilled to highlight Genome BC’s Geneskool program, which provides free remote learning resources for in the genomics field. And, if you are looking to meet and network with individuals who are defining the future of precision medicine, UBC’s School of Biomedical Engineering’s Fourth Annual Symposium is open for registration.
Investment opportunities in our sector also continue to make headlines: Epitopea announced a $14 million seed investment from top-tier life sciences investors, including Novateur Ventures. And, InvesTech Vancouver was held at Fasken Canada, a half day program for Canadian companies interested in expanding to the USA.
This week marks the 20th National Immunization Awareness Week. The last few years have proven the importance of immunizations, and we’d like to take this opportunity to recognize the tenacity and dedication of the countless scientists involved in creating vaccines that keep us safe. To this point, the recipients of the seventh annual Governor General’s Innovation Awards have been announced. Among the recipients are Dr. Pieter R. Cullis, Dr. Michael J. Hope, and Dr. Thomas D. Madden, who are collectively being recognized with the Governor General’s Innovation Award for developing systems to enable RNA and DNA based drugs to be used therapeutically.
Lastly, LSBC is proud to host our Showcase Series: Surrey event on May 11th. Register now to learn more about the cutting-edge research being done in Surrey and Greater Vancouver!
Wendy and the LSBC team
|
|
|
|
Support for Scientist-Entrepreneurs Crucial to Rapid Crisis Response
To solve complex problems such as the global pandemic or climate change, society looks to science for solutions. Academic scientists play a central role in the production and translation of breakthrough scientific inventions. However, many breakthrough inventions in science, medicine and engineering operate in environments of high uncertainty. Their development can span decades, leaving great ideas languishing in the lab, instead of thriving as spin-off companies within a robust innovation ecosystem... READ MORE
|
|
|
|
Zymeworks Reports Last Patient Enrolled In Pivotal Study Of Zanidatamab In Treatment Of HER2-Expressing Late-Line Biliary Tract Cancer
Zymeworks Inc., a clinical-stage biopharmaceutical company developing next-generation multifunctional biotherapeutics, announced that it has completed enrollment in its global HERIZON-BTC-01 pivotal clinical trial evaluating the antitumor activity of zanidatamab monotherapy in patients with previously treated advanced or metastatic HER2-amplified biliary tract cancers, including gallbladder cancer and cholangiocarcinoma (bile duct cancer)... READ MORE
|
|
|
|
UBC Team Discovers ‘Silver Bullet’ to Keep Medical Devices Free of Bacteria
The team from UBC and the Vancouver Coastal Health Research Institute has developed a silver-based coating that can easily be applied to devices such as catheters and stents. Their novel formulation, discovered by screening dozens of chemical components, overcomes the complications of silver that have challenged scientists for years... READ MORE
|
|
|
|
Acuitas Therapeutics Founders Receive Governor General’s Innovation Award
The founders of Acuitas Therapeutics, Drs. Pieter Cullis, Michael Hope and Thomas Madden, have been named as Governor General’s Innovation Award recipients. This prestigious award is for their work in developing lipid nanoparticle systems to deliver cancer drugs to tumours and to enable RNA- and DNA-based drugs to be used therapeutically... READ MORE
|
|
|
|
Ontario Strengthens Domestic Pharmaceutical Manufacturing Capacity
The Ontario government is supporting an investment of nearly $15 million by Johnson & Johnson Inc., makers of over-the-counter pharmaceuticals for adults and children. The province is investing $2.5 million through the Ontario Together Fund to help expand the company’s current manufacturing facilities in Guelph... READ MORE
|
|
|
|
Beazley and Cytora Partner to Streamline Insurance for Brokers and Clients
Beazley, a leading global specialist insurer, has partnered with insurtech Cytora to automate risk processing and accelerate profitable growth. By using the Cytora Platform, Beazley will streamline its global risk intake, reduce manual processes and uplift straight-through-processing. Not only will this lead to better, faster service for brokers and clients, it will also reduce costs and accelerate Beazley’s expansion plans in North America and European markets... READ MORE
|
|
|
|
Doping for Bacteria: Evonik Presents New Technology to Boost Efficiency in Wastewater Treatment
Evonik is responding to the challenges of today’s wastewater management with an innovative approach: The specialty chemicals company wants to specifically dope microorganisms that take over important material conversion reactions in the biological treatment of wastewater with oxygen... READ MORE
|
|
|
|
Algernon Pharmaceuticals Announces Lead Chronic Kidney Disease Drug Repirinast Reduced Fibrosis by 56% in a Preclinical NASH Study
Algernon Pharmaceuticals Inc., a clinical stage pharmaceutical development company is pleased to announce that its lead chronic kidney disease drug NP-251 (“Repirinast”), reduced fibrosis by 56% with statistical significance, in a preclinical study investigating non-alcoholic steatohepatitis in the STAM™ mouse model from SMC Laboratories (Japan)... READ MORE
|
|
|
|
How a Million Doses in a Single Test Tube Can Save the World
When most people think about mRNA, they imagine the Pfizer-BioNTech or Moderna jab: the chill of the alcohol swab, the sting of the injection, the flood of relief that comes with knowing you are protected from the virus. When Dr. Anna Blakney thinks about mRNA, her mind immediately travels to the post-COVID future... READ MORE
|
|
|
|
Takeda Recognized as 2022 ISPE Facility of the Year Awards Winner in Two Categories
Takeda announced that the International Society for Pharmaceutical Engineering has awarded the company top honors in the Supply Chain and Pharma 4.0™ categories for the 2022 Facility of the Year Awards. In the Supply Chain category, Takeda was awarded for its implementation of a new patient-focused supply chain for its allogeneic mesenchymal stem cell therapy; and Takeda’s vaccine production facility in Singen, Germany, won in the Pharma 4.0 category... READ MORE
|
|
|
|
CHMP Recommends EU Approval of Roche’s Tecentriq as Adjuvant Treatment for a Subset of People with Early-Stage non-Small Cell Lung Cancer
Roche announced the European Medicines Agency’s Committee for Medicinal Products for Human Use has recommended the approval of Tecentriq® (atezolizumab) as an adjuvant treatment, following complete resection and platinum-based chemotherapy, for adults with non-small cell lung cancer (NSCLC) with a high risk of recurrence whose tumours express PD-L1≥50% and who do not have EGFR mutant or ALK-positive NSCLC... READ MORE
|
|
|
|
Boehringer Ingelheim Launches RenuTend™: a New Stem Cell Therapy to Improve the Healing of Tendon and Suspensory Ligament Injuries in Horses
It takes years of diligent training as well as a trusting relationship between horse and rider to reach their full potential as a team. That’s why a tendon or ligament injury can be devastating for horse owners, riders and trainers. For equine athletes, the diagnosis may mean many months of treatment and rehabilitation with an unknown outcome, and potential for long term impact on their ability to perform... READ MORE
|
|
|
|
‘Made in Canada’ Solution Will Transform Cancer Care For Canadians
There has been a significant decrease in cancer diagnosis and treatment, as health care systems adapt to the demands of the pandemic. Nearly half of Canadians are expected to receive a diagnosis of cancer in their lifetime, and delaying the time between diagnosis and treatment increases risk of dying from cancer by 10%... READ MORE
|
|
|
|
Intellectual Property Made Easy: Goxl Offers Growing Businesses an Online Entry Point into the Universe of IP Protection
Gowling WLG announced the launch of GoXL, an online self-learning platform designed to guide users through the core elements of IP protection. Featuring a rich online library of on-demand tutorials, GoXL helps users recognize the full value of their IP assets – while giving them the legal foundation they need to work most effectively with their IP adviser... READ MORE
|
|
|
|
VantAI Forms Research Collaboration with Boehringer Ingelheim to Identify Novel Protein Degraders
VantAI, an AI-first induced-proximity company, and Boehringer Ingelheim announced that the two companies have entered into an early discovery research collaboration focused on degrading traditionally “undruggable” targets. The collaboration will initially focus on one degrader program combined with multiple proprietary E3 ligase platforms... READ MORE
|
|
|
|
‘Significant Milestone’: Canada’s Blood Ban Will Soon be Eradicated
A policy change years in the making, on Thursday Health Canada approved Canadian Blood Services’ submission to eliminate the three-month donor deferral period for gay and bisexual men as well as some other folks in the LGBTQ2S+ community. Moving away from a blanket ban, the national blood donor organization will be able to screen all donors regardless of gender or sexuality ...READ MORE
|
|
|
|
Moderna Vaccine Manufacturing Plant Coming to Montreal Region
The American pharmaceutical giant Moderna has chosen the greater Montreal area to build its new biomanufacturing plant — the company’s first outside of the United States. The announcement is expected to be made by Prime Minister Justin Trudeau and Quebec Premier François Legault, Radio-Canada has confirmed ...READ MORE
|
|
|
|
Message from the Minister of Health for National Immunization Awareness Week (April 23-30, 2022)
"Today, we mark the beginning of National Immunization Awareness Week, celebrated each year to highlight and recognize the importance of vaccines to our health. Immunization in Canada and around the world has and continues to save more lives than any other health intervention". ..READ MORE
|
|
|
|
Statement by the Prime Minister on National Immunization Awareness Week
The Prime Minister, Justin Trudeau issued the following statement to mark National Immunization Awareness Week, which runs from April 23 to 30, 2022: “Today, as we mark the 20th National Immunization Awareness Week, I want to take the opportunity to thank Canadians for taking part in the largest vaccination campaign in our country’s history. ..READ MORE
|
|
 |
Groupe Parima Inc. has developed an expertise in the development and manufacturing of non-sterile liquids, suspensions, and semi-solid drug products. This strategic focus has allowed them to establish a unique expertise to support your product development and manufacturing needs, which, combined to their operational flexibility and commitment to delivering on time, enables them to operate as an extension of your team.
|
|
|
|
PHEMI Health DataLab is a unique, integrated big data management system that allows healthcare organizations to enhance innovation and generate value from healthcare data by simplifying the ingestion and de-identification of data with NSA/military-grade governance, privacy, and security built-in. PHEMI solves privacy and security challenges and addresses the urgent need to secure, govern, curate, and control access to privacy-sensitive personal healthcare information (PHI).
|
|
|
|
Sr. Associate/Associate, Project Management
Acuitas Therapeutics Inc. is seeking a Sr. Associate/Associate, Project Management who will plan and coordinate projects using project planning and management methods to support departments and cross-functional teams.
|
|
Therapist
Numinus Wellness Inc. is seeking a Therapist experienced in present-moment process-oriented, phenomenological, somatic, and trauma-informed modalities and is interested in providing standard and psychedelic-assisted psychotherapy.
|
|
LSBC Job Board
Jobs posted to our Job Board automatically post out to all our social media accounts for wider sharing. Make sure you include your company name in the first line of your job ad for maximum exposure!
|
|
|
|
Post A Job on the LSBC Website! |
LSBC Membership Discounts on Job Postings
As an LSBC member, your first five job postings EARNS a free repost on BioTalent Canada's The Petri Dish. After your first five reposts, you will also receive 25% off all job postings on The Petri Dish. Want more info? Contact Megan Pan -talent@lifesciencesbc.ca
|
|
|
|
|
|
|
